{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:20:44Z","timestamp":1793838044648,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaip.2024.06.036","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:56:38Z","timestamp":1719500198000},"page":"2325-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update"],"prefix":"10.1016","volume":"12","author":[{"given":"Julie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Waserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.06.036_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.06.036_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaip.2019.11.003","article-title":"Diagnostic challenges in anaphylaxis","volume":"8","author":"Lieberman","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib9","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2022.05.003","article-title":"Incorporating tryptase genotyping into the workup and diagnosis of mast cell diseases and reactions","volume":"10","author":"Lyons","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.anai.2018.07.017","article-title":"The changing face of anaphylaxis in adults and adolescents","volume":"121","author":"Pattanaik","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2019.07.032","article-title":"Earlier ingestion of peanut after changes to infant feeding guidelines: the EarlyNuts study","volume":"144","author":"Soriano","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100449","article-title":"A\u00a0multicenter anaphylaxis registry in Korea: Clinical characteristics and acute treatment details from infants to older adults","volume":"13","author":"Jeong","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.06.036_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jaip.2021.01.010","article-title":"Trends in US emergency department visits for anaphylaxis among infants and toddlers: 2006-2015","volume":"9","author":"Robinson","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2020.09.003","article-title":"Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006-2015","volume":"126","author":"Robinson","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaip.2020.11.005","article-title":"Caregiver-reported presentation of severe food-induced allergic reactions in infants and toddlers","volume":"9","author":"Pistiner","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.1486","article-title":"Relevance of casual contact with peanut butter in children with peanut allergy","volume":"112","author":"Simonte","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1034\/j.1398-9995.2002.03366.x","article-title":"Bronchial challenges with aerosolized food in asthmatic, food-allergic children","volume":"57","author":"Roberts","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jaci.2021.01.034","article-title":"Prevention and management of allergic reactions to food in child care centers and schools: practice guidelines","volume":"147","author":"Waserman","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s40521-018-0168-2","article-title":"Risk factors and cofactors for severe anaphylaxis","volume":"5","author":"De Feo","year":"2018","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaip.2021.10.008","article-title":"Fatal food anaphylaxis: distinguishing fact from fiction","volume":"10","author":"Anagnostou","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.anai.2017.07.014","article-title":"Risk factors for severe anaphylaxis in the United States","volume":"119","author":"Motosue","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib28","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/cea.13516","article-title":"Identifying and managing patients at risk of severe allergic reactions to food: report from two iFAAM workshops","volume":"49","author":"Roberts","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib29","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2021.11.e8","article-title":"Predictors of serious outcomes among patients with anaphylaxis seen in the Philippine national tertiary hospital","volume":"11","author":"Tan-Lim","year":"2021","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anai.2018.05.001","article-title":"Epinephrine, auto-injectors, and anaphylaxis: challenges of dose, depth, and device","volume":"121","author":"Brown","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis: a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib32","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jaip.2018.04.036","article-title":"The health and economic outcomes of peanut allergy management practices","volume":"6","author":"Shaker","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15586\/aei.v50i5.582","article-title":"Benefit of educational intervention on autoinjector technique for caregivers and paediatric patients with food allergies: a literature review","volume":"50","author":"Trujillo","year":"2022","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2024.06.036_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000477566","article-title":"Safety of adrenaline use in anaphylaxis: a multicentre register","volume":"173","author":"Cardona","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib36","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jaip.2018.04.006","article-title":"Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature","volume":"6","author":"Shaker","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2018.06.035","article-title":"An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis","volume":"122","author":"Shaker","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib38","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jaip.2022.04.040","article-title":"Acute at-home management of anaphylaxis: 911: what is the emergency?","volume":"10","author":"Casale","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ACI.0000000000000657","article-title":"Beta-Blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?","volume":"20","author":"Smith","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients taking beta-blockers do not require increased doses of epinephrine for anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaci.2005.06.019","article-title":"Beta-blockers and anaphylaxis: are the risks overstated?","volume":"116","author":"Miller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib43","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.jaip.2019.10.020","article-title":"Risk for anaphylactic reaction from cardiac catheterization in patients receiving beta-adrenergic blockers or angiotensin-converting enzyme-inhibitors","volume":"8","author":"Smith","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib44","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaip.2017.05.009","article-title":"Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions","volume":"5","author":"Carlson","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2020.06.008","article-title":"Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry","volume":"147","author":"Francuzik","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib46","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2024.06.036_bib48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for Hymenoptera venom allergy","volume":"115","author":"Muller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib50","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Rueff","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Rueff","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.anai.2016.12.009","article-title":"Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update","volume":"118","author":"Greenhawt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.iac.2021.09.012","article-title":"Systemic allergic reactions and anaphylaxis associated with allergen immunotherapy","volume":"42","author":"Dhamija","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.036_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System","volume":"125","author":"Cox","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib57","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2024.06.036_bib58","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib59","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2222.2009.03251.x","article-title":"Elevated baseline serum tryptase, mastocytosis and anaphylaxis","volume":"39","author":"Muller","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.iac.2014.02.004","article-title":"Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients","volume":"34","author":"Niedoszytko","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.036_bib62","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib63","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.iac.2018.04.010","article-title":"Hymenoptera anaphylaxis as a clonal mast cell disorder","volume":"38","author":"Bonadonna","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.06.036_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","article-title":"A\u00a0distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis","volume":"141","author":"Carter","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib66","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"Selb","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18176\/jiaci.0233","article-title":"Prevalence of clonal mast cell disorders in patients presenting with Hymenoptera venom anaphylaxis might be higher than expected","volume":"28","author":"Vazquez-Revuelta","year":"2018","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"Gulen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib70","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib71","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3324\/haematol.2010.034553","article-title":"Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis","volume":"96","author":"Zanotti","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2024.06.036_bib72","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","article-title":"The normal range of baseline tryptase should be 1 to 15 ng\/mL and covers healthy individuals with H\u237aT","volume":"11","author":"Valent","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.06.036_bib73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ACI.0000000000000781","article-title":"Update on omalizumab in allergen immunotherapy","volume":"21","author":"Dantzer","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.anai.2021.06.017","article-title":"Use of omalizumab for management of idiopathic anaphylaxis: a systematic review and retrospective case series","volume":"127","author":"Kaminsky","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib75","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.06.036_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172335","article-title":"A\u00a0phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis","volume":"133","author":"Suresh","year":"2023","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.06.036_bib77","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2022.08.027","article-title":"Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria","volume":"150","author":"Maurer","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.anai.2020.10.001","article-title":"Incidence of and risk factors for perioperative or periprocedural anaphylaxis in the United States from 2005 to 2014","volume":"126","author":"Gonzalez-Estrada","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.06.036_bib79","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/all.13752","article-title":"Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: an observational study","volume":"74","author":"Vitte","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.06.036_bib80","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0091-6749(97)70222-7","article-title":"Timing of venom skin tests and IgE determinations after insect sting anaphylaxis","volume":"100","author":"Goldberg","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824006731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:29:00Z","timestamp":1730521740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824006731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213219824006731"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.036","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}